Sichuan Baili Pharmaceutical Co Ltd

We track 1 ClinicalTrials.gov studies led by Sichuan Baili Pharmaceutical Co Ltd. The portfolio skews toward Phase 3 (1 trials).

1 clinical trials sponsored by Sichuan Baili Pharmaceutical Co Ltd.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials by Sichuan Baili Pharmaceutical Co Ltd

A Randomized Controlled Phase III Clinical Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer

NCT07518173 · NOT YET RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Sichuan Baili Pharmaceutical Co Ltd sponsor?

Sichuan Baili Pharmaceutical Co Ltd currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 3.

What conditions does Sichuan Baili Pharmaceutical Co Ltd research?

Sichuan Baili Pharmaceutical Co Ltd conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Sichuan Baili Pharmaceutical Co Ltd recruiting for clinical trials?

Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.

Explore More